# 3D Systems Corp: Form 10-Q for the period ended Mar 31, 2017

- Company: [3D Systems Corp](/companies/ddd.md) (CIK 910638)
- Form: 10-Q
- Filed: 2017-05-03
- Accepted by EDGAR: May 3, 2017, 16:02 ET
- Period: 2017-03-31
- Accession: 0000910638-17-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/910638/000091063817000007/ddd-20170331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/910638/000091063817000007/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-01-01 to 2017-03-31 | $76.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2017-01-01 to 2017-03-31 | $80.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2017-01-01 to 2017-03-31 | $22.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-01-01 to 2017-03-31 | $66.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-01-01 to 2017-03-31 | −$9.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2017-01-01 to 2017-03-31 | $1.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-01-01 to 2017-03-31 | −$10.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-01-01 to 2017-03-31 | −$0.09 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2017-01-01 to 2017-03-31 | $19.4m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2017-01-01 to 2017-03-31 | $5.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2017-03-31 | $161.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-03-31 | $409.3m | us-gaap:AssetsCurrent |
| Total assets | at 2017-03-31 | $865.6m | us-gaap:Assets |
| Current liabilities | at 2017-03-31 | $141.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-03-31 | $222.3m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-03-31 | $637.5m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,389 characters.

This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Item 1 (the “Financial Statements”) of this Quarterly Report on Form 10-Q (“Form 10-Q”). We are subject to a number of risks and uncertainties that may affect our future performance that are discussed in greater detail in the sections entitled “Forward-Looking Statements” at the end of this Item 2 and that are discussed or referred to in Item 1A of Part II of this Form 10-Q.

### Business Overview

3D Systems Corporation (“3D Systems” or the “Company” or “we” or “us”) is a holding company incorporated in Delaware in 1993 that operates through subsidiaries in North America and South America (collectively referred to as “Americas”), Europe and the Middle East (collectively referred to as “EMEA”) and the Asia Pacific region (“APAC”). We market our products and services in those areas as well as in other parts of the world. We provide comprehensive 3D printing solutions, including 3D printers, print materials, software, on-demand manufacturing services and digital design tools. Our precision healthcare capabilities include simulation, Virtual Surgical Planning (“VSP™”), and printing of medical and dental devices and surgical guides and instruments. Our solutions support advanced applications in a wide range of industries including healthcare, aerospace, automotive and durable goods. 3D Systems has a 30 year history of experience and expertise which have proven vital to our development of an ecosystem that enables customers to optimize product designs, transform workflows, bring innovative products to market and drive new business models.

Customers can use our 3D printing solutions to design and manufacture complex and unique parts, eliminate expensive tooling, produce parts locally or in small batches and reduce lead times and time to market. A growing number of customers are shifting from prototyping applications to also using 3D printing for production. We believe this shift will be further driven by our continued advancement and innovation of 3D printing solutions that improve durability, repeatability, productivity and total cost of operations.

### Recent Developments

On January 31, 2017, we announced the acquisition of Vertex-Global Holding B.V. (“Vertex”), a provider of dental materials worldwide under the Vertex and NextDent brands. Vertex Dental and NextDent are manufacturers of photopolymer, thermoplastic, polymer and monomer materials for traditional and 3D printing dental applications. NextDent has developed 12 dental 3D printing materials to date and has obtained regulatory approval for use of these materials in more than 70 countries worldwide. NextDent’s portfolio of 3D printing materials allow dental professionals to produce trays, models, drilling templates, dentures, orthodontic splints, crowns and bridges with enhanced speed, precision and efficiency and lower cost compared to conventional procedures. We believe together, our Figure 4 platform and NextDent’s advanced 3D printing materials provide a strategic foothold in the multi-billion-dollar digital dentistry opportunity and will deliver materials innovation, regulatory compliance, manufacturing efficiency and vertical solutions expertise to advance our solutions across healthcare and other verticals.

### Summary of 2017 Financial Results

Total consolidated revenue for the quarter ended March 31, 2017 increased by 2.6%, or $3.9 million, to $156.4 million, compared to $152.6 million for the quarter ended March 31, 2016. These results reflect an increase in materials and services revenue, partially offset by a decrease in products revenue, as further discussed below.

Healthcare revenue includes sales of products, materials and services for healthcare-related applications, including simulation, training and planning, 3D printing of surgical guides and instruments and medical and dental devices. For the quarter ended March 31, 2017, healthcare revenue increased by 29.0%, to $43.2 million, and made up 27.6% of total revenue, compared to $33.5 million, or 21.9% of total revenue for the quarter ended March 31, 2016. The increase in healthcare revenue reflects increased products and services sales that were driven by customers increasing their investments and expanding their capabilities in precision healthcare, coupled with the acquisition of Vertex.

For the quarter ended March 31, 2017, total software revenue from products and services increased by 0.5%, to $20.4 million, and made up 13.0% of total revenue, compared to $20.3 million, or 13.3% of total revenue for the quarter ended March 31, 2016.

As of March 31, 2017 and December 31, 2016, our backlog was $34.6 million and $31.7 million, respectively. Production and delivery of our printers is generally not characterized by long lead times; backlog is more dependent on timing of customers’ requested deliveries. In addition, on-demand parts services lead time and backlog depends on whether orders are for rapid prototyping or longer-range production runs. As of March 31, 2017, backlog included $8.7 million of on-demand parts manufacturing service orders, compared to $9.2 million at December 31, 2016.

Gross profit for the quarter ended March 31, 2017 increased by 3.4%, or $2.7 million, to $80.2 million, compared to $77.5 million for the quarter ended March 31, 2016. Gross profit margin for the quarters ended March 31, 2017 and 2016 was 51.3% and 50.8%, respectively. Our shift away from lower margin consumer products combined with cost reduction efforts drove higher gross profit and margin.

Operating expenses for the quarter ended March 31, 2017 decreased by 5.3%, or $5.0 million, to $89.3 million, compared to $94.3 million for the quarter ended March 31, 2016. These results primarily reflect lower selling, general and administrative expense, partially offset by higher research and development expense, as further discussed below.

Our operating loss for the quarter ended March 31, 2017 was $9.1 million, compared to an operating loss of $16.8 million for the quarter ended March 31, 2016, reflecting higher gross profit and lower operating expenses, as further discussed below.

For the quarters ended March 31, 2017 and 2016, we generated $19.4 million and $18.1 million of cash in operations, respectively, as further discussed below. In total, our unrestricted cash balance at March 31, 2017 and December 31, 2016 was $161.7 million and $184.9 million, respectively.

### Results of Operations – Quarter Comparison

#### First quarter comparison of revenue by class

We earn revenues from the sale of products, materials and services. The products category includes 3D printers, healthcare simulators and digitizers, as well as software, 3D scanners and haptic devices. The materials category includes a wide range of print materials to be used with our 3D printers, the majority of which are proprietary. The services category includes warranty and maintenance on 3D printers and simulators, software maintenance, on-demand solutions and healthcare services.

Due to the relatively high price of certain 3D printers and a corresponding lengthy selling cycle and relatively low unit volume of the higher priced printers in any particular period, a shift in the timing and concentration of orders and shipments from one period to another can affect reported revenue in any given period. Revenue reported in any particular period is also affected by timing of revenue recognition under rules prescribed by U.S. generally accepted accounting principles (“GAAP”).

In addition to changes in sales volumes, including the impact of revenue from acquisitions, there are two other primary drivers of changes in revenue from one period to another: (1) the combined effect of changes in product mix and average selling prices, sometimes referred to as price and mix effects, and (2) the impact of fluctuations in foreign currencies. As used in this Management’s Discussion and Analysis, the price and mix effects relate to changes in revenue that are not able to be specifically related to changes in unit volume.

Table 1 sets forth the change in revenue by class for the quarters ended March 31, 2017 and 2016:

### Table 1

*(Dollars in thousands)*

|  | Products |  | Materials |  | Services |  | Totals |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue – first quarter 2016 | $52,495 | 34.4% | $38,469 | 25.2% | $61,591 | 40.4% | $152,555 | 100% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | 435 | 0.8 | 6,813 | 17.7 | 975 | 1.6 | 8,223 | 5.4 |
| Price/Mix | (424) | (0.8) | (1,564) | (4.1) | — | — | (1,988) | (1.3) |
| Foreign currency translation | (599) | (1.1) | (895) | (2.3) | (865) | (1.4) | (2,359) | (1.5) |
| Net change | (588) | (1.1) | 4,354 | 11.3 | 110 | 0.2 | 3,876 | 2.6 |
| Revenue – first quarter 2017 | $51,907 | 33.2% | $42,823 | 27.4% | $61,701 | 39.4% | $156,431 | 100% |

Total consolidated revenue increased by 2.6%, primarily driven by higher healthcare revenue coupled with the acquisition of Vertex.

For the quarters ended March 31, 2017 and 2016, software revenue included in the products category, including scanners and haptic devices, contributed $9.8 million.

The increase in materials revenue primarily reflects increased demand for materials driven by industrial customers with production printers, coupled with the acquisition of Vertex.

The increase in services revenue reflects increased demand for healthcare services and our expanded software offering, which were partially offset by a decrease in on-demand parts manufacturing services. For the quarter ended March 31, 2017, services revenue from on-demand parts manufacturing services decreased 6.2% to $25.1 million, compared to $26.8 for quarter ended March 31, 2016. For the quarters ended March 31, 2017 and 2016, software services contributed $10.6 million and $10.5 million, respectively.

#### First quarter comparison of revenue by geographic region

Table 2 sets forth the change in revenue by geographic region for the quarters ended March 31, 2017 and 2016:

### Table 2

*(Dollars in thousands)*

|  | Americas |  | EMEA |  | Asia Pacific |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue – first quarter 2016 | $83,490 | 54.7% | $47,431 | 31.1% | $21,634 | 14.2% | $152,555 | 100% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | (1,512) | (1.8) | 5,937 | 12.5 | 3,798 | 17.6 | 8,223 | 5.4 |
| Price/Mix | (1,864) | (2.2) | 1,866 | 3.9 | (1,990) | (9.2) | (1,988) | (1.3) |
| Foreign currency translation | 177 | 0.2 | (2,276) | (4.8) | (260) | (1.2) | (2,359) | (1.5) |
| Net change | (3,199) | (3.8) | 5,527 | 11.6 | 1,548 | 7.2 | 3,876 | 2.6 |
| Revenue – first quarter 2017 | $80,291 | 51.3% | $52,958 | 33.9% | $23,182 | 14.8% | $156,431 | 100% |

The decrease in revenue in the Americas region primarily reflects lower sales of 3D printers and on-demand parts manufacturing services, partially offset by increased healthcare-related solutions. The increase in revenue in the EMEA and Asia Pacific regions primarily reflects increased sales of materials, coupled with the acquisition of Vertex.

For the quarters ended March 31, 2017 and 2016, revenue from operations outside the U.S., including Latin America, EMEA and APAC, was 50.2% and 49.8% of total revenue, respectively.

#### Gross profit and gross profit margins

Table 3 sets forth gross profit and gross profit margins for the quarters ended March 31, 2017 and 2016:

### Table 3

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2017 Gross Profit | Gross Profit Margin | 2016 Gross Profit | Gross Profit Margin | Change in Gross Profit $% |  | Change in Gross Profit Margin Percentage Points% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Products | $18,293 | 35.2% | $16,805 | 32.0% | $1,488 | 8.9% | 3.2 | 10.1% |
| Materials | 31,689 | 74.0 | 29,998 | 78.0 | 1,691 | 5.6 | (4.0) | (5.1) |
| Services | 30,204 | 49.0 | 30,710 | 49.9 | (506) | (1.6) | (0.9) | (1.9) |
| Total | $80,186 | 51.3% | $77,513 | 50.8% | $2,673 | 3.4% | 0.5 | 0.9% |

The increase in total consolidated gross profit is primarily driven by higher products and materials gross profit, as further discussed below.

Gross profit margin for products increased, primarily due to cost reduction measures and a favorable impact to sales mix from our shift away from lower margin consumer products.

Gross profit margin for materials decreased, primarily due to an unfavorable impact of mix.

Gross profit margin for services decreased, primarily driven by lower field service margins, partially offset by increased on-demand parts manufacturing services margins. On-demand parts manufacturing services gross profit margin increased to 42.5% for the quarter ended March 31, 2017, compared to 41.8% for the quarter ended March 31, 2016.

#### Operating expenses

Table 4 sets forth the components of operating expenses for the quarters ended March 31, 2017 and 2016:

### Table 4

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2017 Amount | % Revenue | 2016 Amount | % Revenue | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative expenses | $66,405 | 42.5% | $73,967 | 48.5% | $(7,562) | (10.2)% |
| Research and development expenses | 22,852 | 14.6 | 20,305 | 13.3 | 2,547 | 12.5 |
| Total operating expenses | $89,257 | 57.1% | $94,272 | 61.8% | $(5,015) | (5.3)% |

Total operating expenses decreased, reflecting lower selling, general and administrative expenses, partially offset by higher research and development expenses, as discussed below.

Selling, general and administrative expenses decreased primarily due to a $5.5 million decrease in compensation costs driven by lower stock based compensation expense and $2.2 million decrease in bad debt expense.

Research and development expenses increased primarily due to a $1.4 million increase in compensation costs related to increased staffing, a $0.6 million increase in outside services associated with product development and a $0.4 million increase in materials purchases.

#### Loss from operations

Table 5 sets forth operating income (loss) by geographic region for the quarters ended March 31, 2017 and 2016:

### Table 5

*(Dollars in thousands)*

| Income (loss) from operations | Quarter Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Americas | $(13,450) | $(14,186) |
| Germany | 2,057 | 1,011 |
| Other EMEA | (1,524) | (8,118) |
| Asia Pacific | 4,341 | 5,182 |
| Subtotal | (8,576) | (16,111) |
| Inter-segment elimination | (495) | (648) |
| Total | $(9,071) | $(16,759) |

The improvement in operating loss was primarily driven by lower operating expenses. See “*Gross profit and gross profit margins”* and “*Operating expenses”* above.

With respect to the Americas, for the quarters ended March 31, 2017 and 2016, the changes in operating loss reflected the same factors relating to our consolidated operating loss that are discussed above. The changes in operating loss in our operations outside the Americas for the quarters ended March 31, 2017 and 2016 resulted primarily from transfer pricing, changes in sales volume and foreign currency translation.

#### Interest and other income, net

Table 6 sets forth the components of interest and other income, net, for the quarters ended March 31, 2017 and 2016:

### Table 6

*(Dollars in thousands)*

| Interest and other expense, net: | Quarter Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Interest income | $(167) | $(216) |
| Foreign exchange gain | (329) | (1,518) |
| Interest expense | 230 | 420 |
| Other expense, net | 65 | 1,188 |
| Total interest and other income, net | $(201) | $(126) |

#### Provision for income taxes

For the quarters ended March 31, 2017 and 2016, we recorded a $1.0 million and $1.2 million provision for income taxes, respectively.

#### Net loss

Table 7 sets forth the primary components of net loss attributable to 3D Systems for the quarters ended March 31, 2017 and 2016:

### Table 7

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2017 | 2016 | Change |
| --- | ---: | ---: | ---: |
| Operating loss | $(9,071) | $(16,759) | $7,688 |
| Less: |  |  |  |
| Interest and other income, net | (201) | (126) | (75) |
| Provision for income taxes | 1,041 | 1,179 | (138) |
| Net income (loss) attributable to noncontrolling interests | 60 | (24) | 84 |
| Net loss attributable to 3D Systems | $(9,971) | $(17,788) | $7,817 |
| Net loss per share — basic and diluted | $(0.09) | $(0.16) |  |

22

### Liquidity and Capital Resources

### Table 8

*(Dollars in thousands)*

|  | March 31, 2017 | December 31, 2016 | Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Cash and cash equivalents | $161,662 | $184,947 | $(23,285) | (12.6)% |
| Accounts receivable: |  |  |  |  |
| Gross accounts receivable | 136,005 | 140,034 | (4,029) | (2.9) |
| Allowance for doubtful accounts | (11,424) | (12,920) | 1,496 | (11.6) |
| Accounts receivable, net | 124,581 | 127,114 | (2,533) | (2.0) |
| Inventories: |  |  |  |  |
| Raw materials | 44,828 | 45,122 | (294) | (0.7) |
| Work in process | 4,143 | 3,109 | 1,034 | 33.3 |
| Finished goods | 68,340 | 69,870 | (1,530) | (2.2) |
| Inventories, gross | 117,311 | 118,101 | (790) | (0.7) |
| Inventory reserves | (12,206) | (14,770) | 2,564 | (17.4) |
| Inventories, net | 105,105 | 103,331 | 1,774 | 1.7 |
| Prepaid expenses and other current assets | 17,909 | 17,558 | 351 | 2.0 |
| Total current assets | $409,257 | $432,950 | $(23,693) | (5.5)% |
| Current portion of debt and capitalized lease obligations | 584 | 572 | 12 | 2.1 |
| Accounts payable | 40,752 | 40,514 | 238 | 0.6 |
| Accrued and other liabilities | 48,736 | 49,968 | (1,232) | (2.5) |
| Customer deposits | 6,549 | 5,857 | 692 | 11.8 |
| Deferred revenue | 45,079 | 33,494 | 11,585 | 34.6 |
| Total current liabilities | $141,700 | $130,405 | $11,295 | 8.7% |
| Working capital | $267,557 | $302,545 | $(34,988) | (11.6)% |
| Stockholders' equity attributable to 3D Systems Corporation | $637,504 | $629,873 | $7,631 | 1.2% |

We believe our existing cash and cash equivalents will be sufficient to satisfy our working capital needs, capital expenditures, outstanding commitments and other liquidity requirements associated with our existing operations in the foreseeable future, or to consummate significant acquisitions of other businesses, assets, products or technologies. However, it is possible that, in the future, we may need to raise additional funds to finance our activities. If needed, we may be able to raise such funds by issuing equity or debt securities to the public or selected investors, by borrowing from financial institutions, drawing down on our credit facility, selling assets or restructuring debt. There is no assurance, however, that funds will be available from these sources in the amounts or on terms acceptable to us.

If we need to raise additional funds in the future to fund our activities, or for other reasons, and raise additional funds by issuing equity or convertible debt securities, the ownership percentages of existing shareholders would be diluted. In addition, the equity or debt securities that we may issue may have rights, preferences or privileges senior to those of our common stock.

Cash held outside the U.S. at March 31, 2017 was $87.0 million, or 53.8% of total cash and equivalents, compared to $83.5 million, or 45.2% of total cash and equivalents at December 31, 2016. Cash held outside the U.S. is used in our foreign operations for working capital purposes and is considered to be permanently invested; consequently, we have not provided for any taxes on repatriation.

Cash equivalents comprise funds held in money market instruments and are reported at their current carrying value, which approximates fair value due to the short term nature of these instruments. We strive to minimize our credit risk by investing primarily in investment grade, liquid instruments and limit exposure to any one issuer depending upon credit quality. See *Cash flow, Credit facilities* and *Capitalized lease obligations* below.

Days’ sales outstanding was 72 days at March 31, 2017 compared to 70 days at December 31, 2016 and accounts receivable more than 90 days past due decreased to 9.8% of gross receivables, from 12.5% at December 31, 2016. We review specific receivables periodically to determine the appropriate reserve for accounts receivable.

The majority of our inventory consists of finished goods, including products, materials and service parts. Inventory also consists of raw materials and spare parts for the in-house assembly and support service products. We outsource the assembly of certain 3D printers; therefore, we generally do not hold most parts for the assembly of these printers in inventory.

The changes that make up the other components of working capital not discussed above arose in the ordinary course of business. Differences between the amounts of working capital item changes in the cash flow statement and the balance sheet changes for the corresponding items are primarily the result of foreign currency translation adjustments.

#### Cash flow

Table 9 summarizes the cash provided by (used in) operating activities, investing activities and financing activities, as well as the effect of changes in foreign currency exchange rates on cash, for the quarters ended March 31, 2017 and 2016:

### Table 9

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Cash provided by operating activities | $19,381 | $18,118 |
| Cash used in investing activities | (40,167) | (4,477) |
| Cash used in financing activities | (4,436) | (1,072) |
| Effect of exchange rate changes on cash | 1,937 | 1,562 |
| Net increase (decrease) in cash and cash equivalents | $(23,285) | $14,131 |

#### Cash flow from operating activities

Table 10 summarizes the components of cash provided by operating activities for the quarters ended March 31, 2017 and 2016:

### Table 10

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Net loss | $(9,911) | $(17,812) |
| Non-cash charges | 21,190 | 28,052 |
| Changes in working capital and all other operating assets | 8,102 | 7,878 |
| Net cash provided by operating activities | $19,381 | $18,118 |

For further discussion of net loss, see “*Net loss”* above. Non-cash charges primarily consist of depreciation, amortization and stock-based compensation. For further discussion of changes in working capital, see “*Liquidity and Capital Resour*ces” above. Differences between the amounts of working capital item changes in the cash flow statement and the balance sheet changes for the corresponding items are primarily the result of foreign currency translation adjustments.

#### Cash flow from investing activities

Table 11 summarizes the components of cash used in investing activities for the quarters ended March 31, 2017 and 2016:

### Table 11

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Cash paid for acquisitions, net of cash assumed | $(34,291) | $— |
| Purchases of property and equipment | (5,620) | (4,246) |
| Proceeds from disposition of property and equipment | 24 | — |
| Additions to license and patent costs | (280) | (231) |
| Net cash used in investing activities | $(40,167) | $(4,477) |

24

See Note 2 to the condensed consolidated financial statements for further discussion of acquisition activity. Capital expenditures primarily consisted of expenditures for leasehold improvements, including expanding facilities and investing in infrastructure, equipment to support our on-demand parts manufacturing service and printers associated with new product development efforts.

#### Cash flow from financing activities

Table 12 summarizes the components of cash used in financing activities for the quarters ended March 31, 2017 and 2016:

### Table 12

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2017 | 2016 |
| --- | ---: | ---: |
| Payments on earnout consideration | $(3,206) | $— |
| Repurchase of stock, net, and employer paid tax on employee awards | (1,088) | (810) |
| Repayment of capital lease obligations | (142) | (262) |
| Net cash used in financing activities | $(4,436) | $(1,072) |

#### Contractual commitments and off-balance sheet arrangements

#### Credit facilities

In October 2014, we entered into a $150.0 million five-year revolving, unsecured credit facility. The agreement provides for advances in the initial aggregate principal amount of up to $150.0 million. Subject to certain terms and conditions contained in the agreement, we may, at our option, request an increase in the aggregate principal amount available under the credit facility by an additional $75.0 million. As of March 31, 2017 and December 31, 2016, there was no outstanding balance on the credit facility. Based on current financial covenant limitations at March 31, 2017, availability on the credit facility would be approximately $150.0 million. Future results may impact availability. See Note 8 to the condensed consolidated financial statements.

#### Capitalized lease obligations

Our capitalized lease obligations include a lease agreement that we entered into during 2006 with respect to our Rock Hill, SC facility, in addition to other lease agreements assumed through acquisitions. In accordance with ASC 840, “Leases,” we are considered an owner of the properties, therefore, we have recorded these amounts in our consolidated balance sheet with a corresponding capitalized lease obligation in the liabilities section of the consolidated balance sheet. Our outstanding capitalized lease obligations carrying value at March 31, 2017 and December 31, 2016 was $8.0 million and $8.2 million, respectively.

#### Other contractual arrangements

We lease certain of our facilities and equipment under non-cancelable operating leases. For the quarters ended March 31, 2017 and 2016, rent expense under operating leases was $3.7 million and $3.3 million, respectively.

Certain of our acquisition purchase agreements contain earnout payment provisions under which the sellers of the acquired businesses can earn additional amounts. The total amount of liabilities recorded for these earnouts is $7.9 million and $10.8 million at March 31, 2017 and December 31, 2016, respectively.

The minority interest shareholders of a certain subsidiary have the right to require us to acquire either a portion of or all ownership interest under certain circumstances pursuant to a contractual arrangement, and we have a similar call option under the same contractual terms. The amount of consideration under the put and call rights is not a fixed amount, but rather is dependent upon various valuation formulas and on future events, such as revenue and gross margin performance of the subsidiary through the date of exercise, as described in Note 14 to the condensed consolidated financial statements. Management estimates, assuming that the subsidiary owned by us at March 31, 2017 performs over the relevant future periods at its forecasted earnings levels, that these rights, if exercised, could require us in a future period to pay a maximum of approximately $8.9 million to the owners of such put rights. This amount has been recorded as redeemable noncontrolling interests on the balance sheet at March 31, 2017 and December 31, 2016.

#### Off-balance sheet arrangements

We have no off-balance sheet arrangements and do not utilize any “structured debt,” “special purpose,” or similar unconsolidated entities for liquidity or financing purposes.

#### Financial instruments

We conduct business in various countries using both the functional currencies of those countries and other currencies to effect cross border transactions. As a result, we are subject to the risk that fluctuations in foreign exchange rates between the dates that those transactions are entered into and their respective settlement dates will result in a foreign exchange gain or loss. When practicable, we endeavor to match assets and liabilities in the same currency on our balance sheet and those of our subsidiaries in order to reduce these risks. We also, when we consider it to be appropriate, enter into foreign currency contracts to hedge exposures arising from those transactions. See Note 7 to the condensed consolidated financial statements.

We do not hedge for trading or speculative purposes, and our foreign currency contracts are generally short-term in nature, typically maturing in 90 days or less. We have elected not to prepare and maintain the documentation to qualify for hedge accounting treatment under ASC 815, “Derivatives and Hedging,” and therefore, we recognize all gains and losses (realized or unrealized) in interest and other expense, net in our Consolidated Statements of Operations and Other Comprehensive Income (Loss).

Changes in the fair value of derivatives are recorded in interest and other expense, net, in our unaudited condensed consolidated statements of operations and comprehensive income. Depending on their fair value at the end of the reporting period, derivatives are recorded either in prepaid and other current assets or in accrued liabilities in our unaudited condensed consolidated balance sheets.

### Recent Accounting Pronouncements

Our critical accounting policies are disclosed in our 2016 Annual Report on Form 10-K and Note 1 of our condensed consolidated financial statements. The only change to our critical accounting policies during the quarter ended March 31, 2017 was a modification to the way in which we account for forfeitures of share-based awards. Specifically, beginning in the first quarter of 2017, we recognize forfeitures of share-based awards as they occur in the period of forfeiture rather than estimating the number of awards expected to be forfeited at the grant date and subsequently adjusting the estimate when awards are actually forfeited. This change did not have a material impact on our results of operations in the current period, and is not expected to have a material impact on results of operations in subsequent periods

### Critical Accounting Policies and Significant Estimates

For a discussion of our critical accounting policies and estimates, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Significant Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2016 (“Form 10-K”).

### Forward-Looking Statements

Certain statements made in this Form 10-Q that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In many cases, you can identify forward-looking statements by terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates,” or “plans” or the negative of these terms or other comparable terminology.

Forward-looking statements are based upon management’s beliefs, assumptions and current expectations concerning future events and trends, using information currently available, and are necessarily subject to uncertainties, many of which are outside our control. Although we believe that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at or by which any such performance or results will be achieved. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements. These factors include without limitation:

- competitive industry pressures;
- our ability to deliver products that meet changing technology and customer needs;
- our ability to identify strategic acquisitions, to integrate such acquisitions into our business without disruption and to realize the anticipated benefits of such acquisitions;
- impact of future write-off or write-downs of intangible assets;
- our ability to acquire and enforce intellectual property rights and defend such rights against third party claims;
- our ability to protect our intellectual property rights and confidential information, including our digital content, from third-party infringers or unauthorized copying, use or disclosure;
- failure of our information technology infrastructure or inability to protect against cyber-attack;
- our ability to generate net cash flow from operations;
- our ability to obtain additional financing on acceptable terms;
- impact of global economic, political and social conditions and financial markets on our business;
- fluctuations in our gross profit margins, operating income or loss and/or net income or loss;
- our ability to efficiently conduct business outside the U.S.;
- our dependence on our supply chain for components and sub-assemblies used in our 3D printers and other products and for raw materials used in our print materials;
- our ability to manage the costs and effects of litigation, investigations or similar matters involving us or our subsidiaries;
- product quality problems that result in decreased sales and operating margin, product returns, product liability, warranty or other claims;
- our ability to retain our key employees and to attract and retain new qualified employees, while controlling our labor costs;
- our exposure to product liability claims and other claims and legal proceedings;
- disruption in our management information systems for inventory management, distribution, and other key functions;
- compliance with U.S. and other anti-corruption laws, trade controls, economic sanctions, and similar laws and regulations;
- changes in, or interpretation of, tax rules and regulations; and
- compliance with, and related expenses and challenges concerning, conflict-free minerals regulations; and
- the other factors discussed in the reports we file with or furnishes to the SEC from time to time, including the risks and important factors set forth in additional detail in “Risk Factors” in Part I, Item 1A of our Form 10-K filed with the SEC.

Certain of these and other factors are discussed in more detail in “Item 1A. Risk Factors” of our Form 10-K. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements included herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update or review any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or circumstances or otherwise. All subsequent written or oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by the cautionary statements referenced above.

## Market risk

As filed, 323 characters.

For a discussion of market risks at December 31, 2016, refer to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” in our Form 10-K. During the first quarter of 2017, there were no material changes or developments that would materially alter the market risk assessment performed as of December 31, 2016.

## Controls and procedures

As filed, 1,981 characters.

#### Evaluation of disclosure controls and procedures

As of March 31, 2017, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) pursuant to Rules 13a-15 and 15d-15 under the Exchange Act. These controls and procedures were designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures. Based on this evaluation, including an evaluation of the rules referred to above in this Item 4, management has concluded that our disclosure controls and procedures were effective as of March 31, 2017 to provide reasonable assurance that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures.

### Changes in Internal Controls over Financial Reporting

There were no material changes in our internal controls over financial reporting during the period covered by this Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed May 3, 2017.
Source: SEC EDGAR, the filing index for accession 0000910638-17-000007. Last ingested by Listed: Nov 15, 2026, 00:01 ET. No prices; not investment advice.
